Table 2. Summary of expression and function of selected miRNAs as markers of disease activity and hypothesized role in AxSpA.
miRNA | Diagnosis | Disease activity | Treatment response | Hypothesized role in AxSpA | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
HC vs. AxSpAT | HC vs. nr-AxSpA | HC vs. AS | nr-AxSpA vs. AS | nr-AxSpA | AS | sacroiliitis | AS II-V | NSAID vs. antiTNF | DMARDs. vs. antiTNF | ||
miR-19a-3p | * | - | ** | * | - | - | - | - | - | ** | bone formation |
miR-24-3p | * | - | ** | ** | - | - | - | - | *** | *** | bone formation |
miR-27a-3p | ** | - | *** | ** | - | - | - | - | *** | ** | bone formation |
miR-29a-3p | ** | - | *** | * | - | - | - | BASDAI, CRP | * | ** | bone formation, |
miR-99b-5p | ** | - | *** | * | CRP | BASDAI | - | - | *** | ** | bone formation |
miR-106a-5p | - | - | ** | ** | - | - | - | - | *** | *** | bone formation |
miR-133a-3p | * | - | * | - | - | BASDAI | - | CRP | - | * | differentiation? |
miR-140-3p | - | - | * | ** | CRP | - | - | - | ** | ** | inflammation |
miR-145-5p | - | - | * | - | CRP | - | - | - | ** | * | bone formation |
miR-146a-5p | * | - | ** | * | - | CRP | - | - | * | * | inflammation |
miR-146b-5p | * | - | ** | ** | - | - | - | - | ** | *** | migration, invasion |
miR-151a-3p | - | - | * | * | - | CRP | - | CRP | - | - | migration |
miR-181a-5p | - | - | - | - | - | CRP | - | - | - | - | ? |
miR-221-3p | - | - | ** | * | - | CRP | - | - | - | * | immunopathogenesis |
miR-222-3p | *** | - | *** | * | - | - | - | BASDAI | - | - | bone formation |
miR-223-3p | * | - | ** | * | - | - | - | - | ** | ** | bone formation |
miR-374a-5p | ** | - | *** | * | CRP | - | - | - | * | * | bone formation |
miR-375 | * | - | - | - | - | - | - | BASDAI | - | - | bone formation |
miR-409-3p | ** | - | *** | - | - | - | - | CRP | - | - | proliferation, invasion |
miR-625-3p | *** | * | *** | - | - | BASDAI | - | BASDAI | - | - | ? |
miR-885-5p | - | - | - | - | - | BASDAI | - | BASDAI | - | - | ? |
Abbreviations: HC, healthy controls; nr-AxSpA, non-radiographic axial spondyloarthritis; AS, ankylosing spondylitis; AS II-V, ankylosing spondylitis with spinal involvement; DMARDs, disease modifying antirheumatic drugs; NSAID, non-steroidal anti-inflammatory drugs; T, T test; -, not significant;
*p<0.05,
**p<0.01,
***p<0.001.
Statistical significance was calculated using ANOVA unless stated otherwise.